Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ's Adoptive Cell Therapy Programs

Friday, December 06, 2019

MaxCyte the global cellbased therapies and life sciences company and KSQ Therapeutics a biotechnology company using its proprietary CRISPRomics discovery platform to achieve higher probabilities of success in drug development announced today that the...

LEO Pharma and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device

Thursday, December 05, 2019

LEO Pharma AS and Portal Instruments today announced a global collaboration and license agreement to develop Portals innovative needlefree drug delivery system for use in combination with LEO Pharmas portfolio of investigational and approved medicine...

Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery

Thursday, December 05, 2019

Gatehouse Bio a pioneer in nextgeneration therapeutics is collaborating with AstraZeneca a global scienceled biopharmaceutical company to explore the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bios Artif...

Resonant Therapeutics Announces Collaboration with Janssen

Wednesday, December 04, 2019

Resonant Therapeutics Inc announced that the company has entered into an agreement with Janssen Research and Development LLC Janssen with the aim to discover and validate novel tumor and immunological targets and to validate certain therapeutic candi...

RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

Wednesday, December 04, 2019

RAPT Therapeutics Inc a clinicalstage immunologybased biopharmaceutical company focused on discovering developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases and Ha...

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics

Tuesday, December 03, 2019

Astellas Pharma Inc and Audentes Therapeutics Inc today announced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price of US per share in cash representing a total equity value of approximately US billionRece...

Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy

Tuesday, December 03, 2019

Neurocrine Biosciences Inc and Xenon Pharmaceuticals Inc announced a license and collaboration agreement to develop firstinclass treatments for epilepsyNeurocrine Biosciences gains an exclusive license to XEN a clinical stage selective Nav sodium cha...

Innovent Biologics Announces FDA Acceptance of NDA for Pemigatinib in Patients

Monday, December 02, 2019

Innovent Biologics Inc Innovent or the Company HKEX a worldclass biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology autoimmune metabolic and other major diseases today announced that the n...

WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products

Friday, November 29, 2019

WuXi ATU Co Ltd a subsidiary of WuXi AppTec and GeneMedicine a South Koreabased gene therapy biotechnology company have formed a strategic partnership for the development and manufacturing of oncolytic virus products Under the terms of the collabor...

Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102

Thursday, November 28, 2019

Verrica Pharmaceuticals Inc a medical dermatology company today announced that its New Drug Application NDA for VP cantharidin Topical Solution a proprietary topical therapy for the treatment of molluscum contagiosum molluscum has been accepted for...